Vitrolife AB banner

Vitrolife AB
SWB:VTFN

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
SWB:VTFN
Watchlist
Price: 8.06 EUR -5.29% Market Closed
Market Cap: €3.5B

Wall Street
Price Targets

VTFN Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VTFN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTFN is 15.21 EUR with a low forecast of 9.41 EUR and a high forecast of 21.04 EUR.

Lowest
Price Target
9.41 EUR
17% Upside
Average
Price Target
15.21 EUR
89% Upside
Highest
Price Target
21.04 EUR
161% Upside
Vitrolife AB Competitors:
Price Targets
ANY
ANY Biztonsagi Nyomda Nyrt
-3% Downside

Revenue
Forecast

18% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
18% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Vitrolife AB's revenue is 18%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

21% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
21% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 14 years the compound annual growth rate for Vitrolife AB's operating income is 21%. The projected CAGR for the next 3 years is 20%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTFN's stock price target?
Price Target
15.21 EUR

According to Wall Street analysts, the average 1-year price target for VTFN is 15.21 EUR with a low forecast of 9.41 EUR and a high forecast of 21.04 EUR.

What is Vitrolife AB's Revenue forecast?
Projected CAGR
6%

For the last 14 years the compound annual growth rate for Vitrolife AB's revenue is 18%. The projected CAGR for the next 3 years is 6%.

What is Vitrolife AB's Operating Income forecast?
Projected CAGR
20%

For the last 14 years the compound annual growth rate for Vitrolife AB's operating income is 21%. The projected CAGR for the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett